GILD

Gilead Sciences, Inc. News Headlines

$70
*  
0.72
 negative 
1.04%
Get GILD Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Invest In Gilead Sciences For Long-Term Hepatitis C Franchise
11/4/2013 2:13:00 AM - Seeking Alpha

Gilead Sciences - After Another Amazing Year, It Is Time To Be Cautious
11/1/2013 5:29:00 AM - Seeking Alpha

Halloween Stock Monsters
10/31/2013 6:18:00 PM - Seeking Alpha

Antiviral Franchise Powers Earnings Beat at Gilead - Analyst Blog
10/30/2013 11:30:01 AM - Zacks.com

After-Hours Earnings Report for October 29, 2013 : GILD, BIDU, AFL, LNKD, AMP, VRTX, BXP, EIX, FISV, RRC, WU, KIM
10/29/2013 2:00:06 PM - NASDAQ.com News

Glaxo Seeks EU Approval for HIV Drug - Analyst Blog
10/28/2013 5:10:01 PM - Zacks.com

Positive CHMP Opinion for Actelion's Opsumit - Analyst Blog
10/28/2013 4:33:09 PM - Zacks.com

Will Gilead (GILD) Disappoint in Q3? - Analyst Blog
10/28/2013 12:10:01 PM - Zacks.com

Cramer's Mad Money - 11 Earnings To Watch In The Week Ahead (10/25/13)
10/28/2013 5:25:00 AM - Seeking Alpha

Earnings: The Long And Short Of It
10/27/2013 6:25:00 PM - Seeking Alpha

Infinity Pharmaceuticals Presents A Compelling Risk Reward Ahead Of Imminent Catalysts
10/25/2013 11:56:00 AM - Seeking Alpha

Stribild Vs. Tivicay In HIV Drug Race
10/24/2013 8:42:00 PM - Seeking Alpha

After Hours Most Active for Oct 24, 2013 : ZNGA, MSFT, CSCO, ABV, AMZN, GILD, BAC, QQQ, KO, CRM, TSM, OZM
10/24/2013 4:31:11 PM - NASDAQ.com News

Top Ranked Biotech ETF in Focus: BBH - ETF News And Commentary
10/24/2013 8:00:01 AM - Zacks.com

United Therapeutics Aims For A Cardiovascular Drug OK
10/22/2013 3:22:00 PM - Investor's Business Daily

Inside Biotech ETFs: Can the Run Continue? - ETF News And Commentary
10/22/2013 10:01:01 AM - Zacks.com

Actelion's Opsumit Cleared in the U.S. - Analyst Blog
10/21/2013 5:07:07 PM - Zacks.com

After Hours Most Active for Oct 18, 2013 : QQQ, RVBD, BAC, SID, ELN, MSFT, RF, GE, CBSH, KMI, CSCO, GILD
10/18/2013 4:43:56 PM - NASDAQ.com News

Gilead Vs. Johnson & Johnson In Cancer Race
10/17/2013 2:01:00 PM - Seeking Alpha

Bullish on Gilead's Stribild - Analyst Blog
10/17/2013 11:50:01 AM - Zacks.com

Stock Market News for October 15, 2013 - Market News
10/15/2013 10:06:01 AM - Zacks.com

MacroGenics - Cancer IPOs Remain The Hottest Thing In Town
10/14/2013 5:27:00 AM - Seeking Alpha

Cramer's Mad Money - FDA Roulette (10/10/13)
10/11/2013 6:52:00 AM - Seeking Alpha

Bayer's Adempas Cleared in the U.S. - Analyst Blog
10/10/2013 4:58:52 PM - Zacks.com

J&J Gains Marginally on HCV Deal - Analyst Blog
10/10/2013 4:30:01 PM - Zacks.com